Shuttle Pharmaceuticals Holdings (SHPH) Amortization of Deferred Charges (2021 - 2022)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Amortization of Deferred Charges came in at $15848.0 in Q4 2022, up 11.54% year-on-year from $14208.0 in Q4 2021, and up 11.54% quarter-over-quarter from $14208.0 in Q4 2021.
Shuttle Pharmaceuticals Holdings (SHPH) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $15848.0 for Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 90.04 Bn | 88.18 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.92 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.44 Mn | 1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 15,848.00 |
| Dec 31, 2022 | 15,848.00 |
| Dec 31, 2021 | 14,208.00 |
| Dec 31, 2021 | 14,208.00 |